Aztramax Pharma Private Limited - Company Profile

It is a business services private limited company based in Coimbatore South, Tamil Nadu, India, established in 2025.
2025 Coimbatore South, Tamil Nadu, India Active
Last Updated:
Access Report
About Aztramax Pharma Private Limited

Aztramax Pharma Private Limited, a active private limited company, was established on 17 July 2025 in Coimbatore South, Tamil Nadu, India. it holds CIN: U46497TZ2025PTC035319. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Formerly known as Aztramax Pharma Private Limited. Its leadership includes Tejpal Kanaklal Abhiachand (Director), Rajpal Kanaklal Abhaichand (Director), Manish Lalitchand Shah (Director). Past directors included Ashwin Kanaklal Shah. It is based at No 64, Race Course Road, Coimbatore South, Tamil Nadu, 641018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497TZ2025PTC035319

  • Registration Number

    035319

  • Incorporation Date

    17 July 2025

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Coimbatore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Months 1 Day
Company report

Aztramax Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aztramax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aztramax Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Tejpal Kanaklal Abhiachand Director 17 Jul 2025 Current
Rajpal Kanaklal Abhaichand Director 17 Jul 2025 Current
Manish Lalitchand Shah Director 17 Jul 2025 Current
Ashwin Kanaklal Shah Director 17 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aztramax Pharma.
Aztramax Pharma revenue growth over time
Aztramax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aztramax Pharma?

Unlock access to Aztramax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aztramax Pharma?

Unlock and access historical data on people associated with Aztramax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aztramax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aztramax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aztramax Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Tejpal Kanaklal Abhiachand was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 1 day . was completed.

  • Director Appointment

    Rajpal Kanaklal Abhaichand was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 1 day . was recorded as a recent event.

  • Director Appointment

    Manish Lalitchand Shah was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 1 day . was recorded as a recent event.

  • Director Appointment

    The activity Ashwin Kanaklal Shah was appointed as a Director was appointed as a Director on 17 Jul 2025 & has been associated with this company since 7 months 1 day . was completed.

  • Company Incorporation

    Aztramax Pharma Private Limited was registered on 17 Jul 2025 with Roc Coimbatore & aged 7 months 1 day as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aztramax Pharma Private Limited?

The CIN of Aztramax Pharma Private Limited is U46497TZ2025PTC035319.

Where is Aztramax Pharma Private Limited headquartered?

Aztramax Pharma Private Limited is headquartered at No 64, Race Course Road, Coimbatore South, Tamil Nadu, 641018.

When was Aztramax Pharma Private Limited incorporated?

Aztramax Pharma Private Limited was incorporated on 17 July 2025.

Who are the current directors of Aztramax Pharma Private Limited?

The current directors of Aztramax Pharma Private Limited are

Is Aztramax Pharma Private Limited a listed company?

Aztramax Pharma Private Limited is unlisted.

What is the capital structure of Aztramax Pharma Private Limited?

The authorized capital of Aztramax Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available